Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

NCT01732250 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

406

Enrollment

OTHER

Sponsor class

Conditions

Gram-Negative Bacterial Infections

Interventions

DRUG: Colistin
DRUG: Meropenem

Sponsor

Mical Paul

Collaborators

[object Object]